Skip to main content

Publications

featured publications

  • Immune Checkpoint Imaging in Oncology: A Game Changer Toward Personalized Immunotherapy?

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine

    Authors: Susanne Lütje, Georg Feldmann, Markus Essler, Peter Brossart, Ralph A Bundschuh

  • Molecular and immune correlates of TIM-3 (HAVCR2) and galectin 9 (LGALS9) mRNA expression and DNA methylation in melanoma.

    Clinical epigenetics

    Authors: Tobias A W Holderried, Luka de Vos, Emma Grace Bawden, Timo J Vogt, Joern Dietrich, Romina Zarbl, Friedrich Bootz, Glen Kristiansen, Peter Brossart, Jennifer Landsberg, Dimo Dietrich

  • A matched-pair analysis on survival and response rates between German and non-German cancer patients treated at a Comprehensive Cancer Center.

    BMC cancer

    Authors: Marie K Budde, Walther Kuhn, Mignon-Denise Keyver-Paik, Friedrich Bootz, Jörg C Kalff, Stefan C Müller, Thomas Bieber, Peter Brossart, Hartmut Vatter, Ulrich Herrlinger, Dieter C Wirtz, Hans H Schild, Glen Kristiansen, Thorsten Pietsch, Stefan Aretz, Franziska Geiser, Lukas Radbruch, Rudolf H Reich, Christian P Strassburg, Dirk Skowasch, Markus Essler, Nicole Ernstmann, Jennifer Landsberg, Benjamin Funke, Ingo G H Schmidt-Wolf

  • Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial.

    Leukemia

    Authors: Laura Cicconi, Uwe Platzbecker, Giuseppe Avvisati, Francesca Paoloni, Christian Thiede, Marco Vignetti, Paola Fazi, Felicetto Ferrara, Mariadomenica Divona, Francesco Albano, Fabio Efficace, Marco Sborgia, Eros Di Bona, Massimo Breccia, Erika Borlenghi, Roberto Cairoli, Alessandro Rambaldi, Lorella Melillo, Giorgio La Nasa, Walter Fiedler, Peter Brossart, Bernd Hertenstein, Helmut R Salih, Ombretta Annibali, Mohammed Wattad, Michael Lubbert, Christian H Brandts, Mathias Hanel, Christoph Rollig, Norbert Schmitz, Hartmut Link, Chiara Frairia, Claudio Fozza, Alfonso Maria D'Arco, Nicola Di Renzo, Agostino Cortelezzi, Francesco Fabbiano, Konstanze Dohner, Arnold Ganser, Hartmut Dohner, Sergio Amadori, Franco Mandelli, Maria Teresa Voso, Gerhard Ehninger, Richard F Schlenk, Francesco Lo-Coco

  • The value of tumor markers in men with metastatic prostate cancer undergoing [ Lu]Lu-PSMA therapy.

    The Prostate

    Authors: Anna Yordanova, Paula Linden, Stefan Hauser, Georg Feldmann, Peter Brossart, Rolf Fimmers, Markus Essler, Stefan Holdenrieder, Hojjat Ahmadzadehfar

  • Nivolumab versus investigator's choice in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: Efficacy and safety in CheckMate 141 by age.

    Oral oncology

    Authors: Nabil F Saba, George Blumenschein, Joel Guigay, Lisa Licitra, Jerome Fayette, Kevin J Harrington, Naomi Kiyota, Maura L Gillison, Robert L Ferris, Vijayvel Jayaprakash, Li Li, Peter Brossart

  • Nivolumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Efficacy and Safety in CheckMate 141 by Prior Cetuximab Use.

    Clinical cancer research : an official journal of the American Association for Cancer Research

    Authors: Robert L Ferris, Lisa Licitra, Jerome Fayette, Caroline Even, George Blumenschein, Kevin J Harrington, Joel Guigay, Everett E Vokes, Nabil F Saba, Robert Haddad, Shanmugasundaram Ramkumar, Jeffery Russell, Peter Brossart, Makoto Tahara, A Dimitrios Colevas, Fernando Concha-Benavente, Mark Lynch, Li Li, Maura L Gillison

  • Nivolumab Alone and With Ipilimumab in Previously Treated Metastatic Urothelial Carcinoma: CheckMate 032 Nivolumab 1 mg/kg Plus Ipilimumab 3 mg/kg Expansion Cohort Results.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology

    Authors: Padmanee Sharma, Arlene Siefker-Radtke, Filippo de Braud, Umberto Basso, Emiliano Calvo, Petri Bono, Michael A Morse, Paolo A Ascierto, Jose Lopez-Martin, Peter Brossart, Kristoffer Rohrberg, Begoña Mellado, Bruce S Fischer, Stephanie Meadows-Shropshire, Abdel Saci, Margaret K Callahan, Jonathan Rosenberg

  • Long Term Remission and Cardiac Toxicity of a Combination of Ipilimumab and Nivolumab in a Patient With Metastatic Head and Neck Carcinoma After Progression Following Nivolumab Monotherapy.

    Frontiers in oncology

    Authors: Katjana S Schwab, Glen Kristiansen, Alexander Isaak, Stefanie E A Held, Annekristin Heine, Peter Brossart

  • Peptide Receptor Radionuclide Therapy Combined With Chemotherapy in Patients With Neuroendocrine Tumors.

    Clinical nuclear medicine

    Authors: Anna Yordanova, Harriet Ahrens, Georg Feldmann, Peter Brossart, Florian C Gaertner, Christian Fottner, Matthias M Weber, Hojjat Ahmadzadehfar, Mathias Schreckenberger, Matthias Miederer, Markus Essler